Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs. Drugs (Pharmaceuticals), Suits and Litigation (Civil), Thalidomide (Drug), Celgene Corporation, Whistle-Blowers, Cancer, Food and Drug Administration